1-149791327-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000566.4(FCGR1A):c.935C>T(p.Thr312Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,447,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T312K) has been classified as Uncertain significance.
Frequency
Consequence
NM_000566.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 2AN: 145642Hom.: 0 Cov.: 26 FAILED QC
GnomAD3 exomes AF: 0.00000407 AC: 1AN: 245836Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133266
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1447862Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 720366
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000137 AC: 2AN: 145642Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 71066
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.935C>T (p.T312I) alteration is located in exon 6 (coding exon 6) of the FCGR1A gene. This alteration results from a C to T substitution at nucleotide position 935, causing the threonine (T) at amino acid position 312 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at